- Dozmorov MG (2009) Unique patterns of
molecular profiling between human prostate
cancer LNCaP and PC-3 cells. Prostate 69
(10):1077–1090 - MuraliKrishna PS (2005) RNA interference-
directed knockdown of urokinase plasmino-
gen activator and urokinase lasminogen acti-
vator receptor inhibits prostate cancer cell
invasion, survival, and tumorigenicity in vivo.
J Biol Chem 280(43):36529–36540 - Lo ́pez-La ́zaro M (2008) The Warburg effect:
why and how do cancer cells activate glycoly-
sis in the presence of oxygen? Science
8:305–312 - Gatenby ET, Gawlinski AF, Gmitro KB, Gil-
lies RJ (2006) Acid-mediated tumor invasion:
a multidisciplinary study. Cancer Res 66
(10):5216–5224 - Rieumont J, Nieto JM, Garcı ́a JM (1997) The
rate of Entropy Production as a mean to
determinate the most important reactions
step in Belousov Zhabotinsky reaction. Anales
de Quı ́mica 93:147–152 - Izquierdo-Kulich E, Alonso-Becerra E,
Nieto-Villar JM (2011) Entropy production
rate for avascular tumor growth. J Mod Phys
2(06):615 - Li X, Dash RK, Pradhan RK, Qi F, Thompson
M et al (2010) A database of thermodynamic
quantities for the reactions of glycolysis and
the tricarboxylic acid cycle. J Phys Chem B
144:16068–16082 - Alberty RA (2006) Biochemical thermody-
namics: applications of mathematica. Wiley-
Interscience, Hoboken, NJ - Montero S, Martin RR, Guerra A,
Casanella O, Cocho G, Nieto-Villar JM
(2016) Cancer glycolysis I: entropy produc-
tion and sensitivity analysis in stationary state.
J Adenocarcinoma 1:1–8 - Parks SK, Chiche J, Pouysse ́gur J (2013) Dis-
rupting proton dynamics and energy metabo-
lism for cancer therapy. Nat Rev Cancer 13
(9):611–623 - Schito L, Semenza GL (2016) Hypoxia-
inducible factors: master regulator of cancer
progression. Trend Cancer 2(12):758–770 - Jun JC, Rathore A, Younas H, Gilkes D,
Polotsky VY (2017) Hypoxia-inducible fac-
tors and cancer. Curr Sleep Med Rep 3
(1):1–10 - Martyushev LM, Seleznev VD (2006) Maxi-
mum entropy production principle in physics,
chemistry and biology. Phys Rep 264(1):1–45 - Nelson DL, Cox N (2013) Lehninger. Prin-
ciples of biochemistry, 6th edn. W. H. Free-
man and Company, New York - Lozupone F, Borghi M, Marzoli F,
Azzarito T, Matarrese P, Lessi E (2015)
TM9SF4 is a novel V-ATPase-interacting pro-
tein that modulates tumor pH alterations
associated with drug resistance and invasive-
ness of colon cancer cells. Oncogene 34
(40):5163–5174 - Fais S, Venturi G, Gatenby B (2014) Micro-
environmental acidosis in carcinogenesis and
metastases: new strategies in prevention and
therapy. Cancer 33:195–108 - Granja S, Tavares-Valente D, Queiro ́s O, Bal-
tazar F (2016) Value of pH regulators in the
diagnosis, prognosis and treatment of cancer.
Semin Cancer Biol. https://doi.org/10.
1016/j.semcancer.2016.12.003 - Sennoune SR, Bakunts K, Martinez GM,
Chua-tuan JL, Kebir Y, Attaya MN,
Martinez-Zaguilan R (2004) Vacuolar Hþ
ATPase in human breast cancer cells with dis-
tinct metastatic potential: distribution and
functional activity. Am J Physiol
286:1443–1452 - Pelicano H, Martin DS, Xu RH, Huang P
(2006) Glycolysis inhibition for anticancer
treatment. Oncogene 25(34):33–46 - Icard P, Lincet H (2012) A global view of the
biochemical pathways involved in the regula-
tion of the metabolism of cancer cells. Bio-
chim Biophys Acta 1826(2):423–433 - Higashimura Y, Nakajima Y, Yamaji R (2011)
Up-regulation of glyceraldehyde-3-phos-
phate dehydrogenase gene expression by
HIF-1 activity depending on Sp1 in hypoxic
breast cancer cells. Arch Biochem Biophys
509(1):1–8 - Liu K, Tang Z, Huang A, Chen P, Liu P, Yang
J (2017) Glyceraldehyde-3-phosphate dehy-
drogenase promotes cancer growth and
metastasis through upregulation of SNAIL
expression. Int J Oncol 50:252–262 - Li X, Gu J, Zhou Q (2015) Review of aerobic
glycolysis and its key enzymes - new targets
for lung cancer therapy. Lung Cancer
6:17–24 - Draoui N, Feron O (2011) Lactate shuttles at
a glance: from physiological paradigms to
anti-cancer treatments. Dis Model Mech
4:727–732 - Hay N (2016) Reprogramming glucose
metabolism in cancer: can it be exploited for
cancer therapy? Nat Rev Cancer 16:635–649 - Mathupala SP, Ko YH, Pedersen PL (2006)
Hexokinase II: cancer’s double-edged sword
acting as both facilitator and gatekeeper of
malignancy when bound to mitochondria.
Oncogene 25:4777–4786
168 Sheyla Montero et al.